Drugs
-
antipsychotics, claims data, drug shortages, Drugs, FDA, first-generation antipsychotics, haloperidol, perphenazine, pharmacy, Psychiatry, psychosis, psychotic disorders, schizophreniaAntipsychotic Shortages Caused Drug Switching: 95,968-Patient Claims Study (2026)
First-generation antipsychotic (FGA) shortages are not just pharmacy annoyances; they force medication…
-
Anxiety, benzodiazepines, depression, Drugs, Iceland, older adults, psychiatric epidemiology, Psychiatry, Psychology, psychotropic prescribing, public-health, registry data, sleep, sleep disordersIceland Psychiatric Data: 21% Diagnosed, 34% on Psychotropics (2026)
Iceland is a registry-rich country with a small enough population that genuinely…
-
antipsychotics, cardiovascular risk, case-control study, cognition, Dementia, Diabetes, Drugs, head injury, integrated care, metabolic syndrome, modifiable risk factors, Neurodegenerative Diseases, Psychiatry, Psychology, psychosis, schizophrenia, smokingSchizophrenia Dementia Risk: Diabetes, Head Injury, Substance Use
Patients with schizophrenia have substantially elevated dementia risk compared to the general…
-
antipsychotics, AUROC, clinical decision support, clozapine, Drugs, electronic health records, InterSePT, machine learning, natural language processing, Psychiatry, psychosis, schizophrenia, treatment-resistant schizophrenia, xgboostMachine Learning Predicts Clozapine Initiation in Schizophrenia
Clozapine is the only medication with proven efficacy for treatment-resistant schizophrenia, yet…
-
5-HT7, acute psychosis, antipsychotics, d2 receptor, Drugs, JEWEL trial, lurasidone, negative symptoms, Neurotransmitters, PANSS, positive symptoms, Psychiatry, psychosis, schizophreniaLurasidone Improves Positive Symptoms of Schizophrenia More Than Negative
Lurasidone is approved for schizophrenia and bipolar depression on the strength of…
-
antidepressants, depression, Drugs, FDA rejection, functional unblinding, Lykos, mdma, media coverage, neuroscience, psilocybin, psychedelic medicine, Psychiatry, Psychology, PTSD, science communication, Stress, treatment-resistant depressionPsychedelic Media Coverage Outpaced Evidence (2017–2024)
Psychedelic-assisted therapy has been one of the most-covered mental-health stories of the…
-
ABCD study, addiction, adolescent, Cannabis, cbd, cognition, cognitive trajectory, Drugs, hair toxicology, longitudinal cohort, marijuana, neurocognition, Prevention, Psychiatry, Psychology, thcTeenage Cannabis Use vs. Cognition and Brain Development: THC vs. CBD (Toxicology Data)
Studies of adolescent cannabis effects on cognition have been limited by self-report…
-
binge eating disorder, Brain, bupropion, contrave, dopamine, Drugs, eating disorders, food reward, human laboratory, lisdexamfetamine, mu-opioid receptor, naltrexone, neuroscience, Neurotransmitters, obesity, POMC neurons, Psychiatry, PsychologyNaltrexone/Bupropion Reduced Food Intake in Binge-Eating Lab Study
Lisdexamfetamine remains the only FDA-approved medication for binge-eating disorder — a serious…
-
18F-DOPA PET, antipsychotics, Brain, caudate, dopamine, dopamine hypothesis, Drugs, longitudinal, neuroimaging, neuroscience, Neurotransmitters, psychosis, relapse, remission, schizophrenia, striatumStriatal Dopamine Drops From Psychosis to Schizophrenia Remission
The dopamine hypothesis of schizophrenia is the field’s longest-running mechanistic story, and…
-
AMPA receptor, antidepressants, Brain, chronic mild stress, comorbidity, depression, Drugs, GluA1, glutamate, ketamine, neuroscience, Neurotransmitters, PTSD, rat model, single prolonged stress, Stress, synaptic plasticityPTSD With Depression Hits AMPA Receptors Harder in Rat Models
PTSD and major depressive disorder co-occur in roughly half of patients with…
